Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2012/073556external-prioritypatent/WO2013079425A1/en
Application filed by Bayer Ip GmbhfiledCriticalBayer Ip Gmbh
Publication of CU20140058A7publicationCriticalpatent/CU20140058A7/en
Nuevos 2H-indazoles de la fórmula general (I), métodos para su preparación y su uso para la producción de agentes farmacéuticos para el tratamiento de enfermedades e indicaciones que están ligadas con el receptor de EP^2.New 2H-indazoles of the general formula (I), methods for their preparation and their use for the production of pharmaceutical agents for the treatment of diseases and indications that are linked with the EP ^ 2 receptor.
CU2014000058A2012-04-242014-05-23
NEW 2H-INDIZOLS AS ANTAGONISTS OF THE EP-2 RECEIVER
CU20140058A7
(en)
N- [4- (QUINOLIN-4-ILOXI) CYCLOHEXIL (METHYL)] (IET) ARIL-CARBOXAMIDS AS ANTAGONISTS OF THE ANDROGEN RECEIVER, ITS PRODUCTION AND USES AS MEDICINAL PRODUCTS
CYCLLOBUTILCARBOXAMIDS, PROCESS FOR PREPARATION, PESTICIDE COMPOSITIONS AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, AND USES OF THE SAME AS NEMATICIDES